Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease (original) (raw)

Effects of standard treatments on depressive/anxiety symptoms in patients with inflammatory bowel disease: A systematic review and meta-analysis

Ali Abdoulaye

General Hospital Psychiatry, 2020

View PDFchevron_right

Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review

mark bernauer

Expert Review of Gastroenterology & Hepatology

View PDFchevron_right

Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease

Benjamin Stern

Inflammatory bowel diseases, 2018

View PDFchevron_right

Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review

Jane Andrews

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Inflammatory bowel disease and anxiety: links, risks, and challenges faced

Ayman Bannaga, Christian Selinger

Clinical and Experimental Gastroenterology, 2015

View PDFchevron_right

Risk factors of anxiety and depression in inflammatory bowel disease

Alain Olympie, Christelle Durance

Inflammatory Bowel Diseases, 2012

View PDFchevron_right

Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients

Antonina Mikocka-walus

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management

Lesley Graff

Inflammatory Bowel Diseases, 2009

View PDFchevron_right

Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease

Maria Ines Sanchez

Inflammatory Bowel Diseases, 2019

View PDFchevron_right

Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability

Miao Shan Lim

Digestive and Liver Disease, 2017

View PDFchevron_right

Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease

Michael Steuerwald

Clinical Gastroenterology and Hepatology, 2016

View PDFchevron_right

Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease

Usha Chauhan

Journal of the Canadian Association of Gastroenterology, 2021

View PDFchevron_right

Antidepressants in Inflammatory Bowel Disease: A Systematic Review

Douglas Drossman

Inflammatory bowel diseases, 2017

View PDFchevron_right

Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease

Jordan Karpin

Gastroenterology Research and Practice

View PDFchevron_right

Psychological factors associated with inflammatory bowel disease

Maria Eugenicos

British Medical Bulletin, 2021

View PDFchevron_right

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease

Justyna Pollok

2019

View PDFchevron_right

Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis

Mamadou Pathé Barry

Therapeutic Advances in Gastroenterology

View PDFchevron_right

Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease

Johanna Escher

Alimentary Pharmacology & Therapeutics, 2018

View PDFchevron_right

Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease

Lesley Graff

Journal of Psychosomatic Research, 2016

View PDFchevron_right

Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort

Glen Bates

Clinical and Experimental Gastroenterology, 2015

View PDFchevron_right

Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care

Laurie Keefer, PhD

Gastroenterology & hepatology, 2017

View PDFchevron_right

A magic pill? A qualitative analysis of patients’ views on the role of antidepressant therapy in inflammatory bowel disease (IBD)

Andrea Gordon, Antonina Mikocka-Walus

BMC Gastroenterology, 2012

View PDFchevron_right

Impact of Depressive Mood on Relapse in Patients With Inflammatory Bowel Disease: A Prospective 18-Month Follow-Up Study

Markus Beier

Psychosomatic Medicine, 2004

View PDFchevron_right

Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a protocol for systematic review of prospective cohort studies

Iain Atherton

Systematic Reviews, 2013

View PDFchevron_right

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis

Lucinda Harris

The American Journal of Gastroenterology, 2019

View PDFchevron_right

Assessment of Comorbid Depression and Anxiety in Inflammatory Bowel Disease Using Adaptive Testing Technology

Tina Rodriguez

Crohn's & Colitis 360, 2021

View PDFchevron_right

The Association Between Depression and Activity of Inflammatory Bowel Disease

Caspian Journal of Neurological Sciences (CJNS)

Caspian Journal of Neurological Sciences, 2023

View PDFchevron_right

Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis

Anderson Loundou

European Archives of Psychiatry and Clinical Neuroscience, 2014

View PDFchevron_right

Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project

Milena Montoya

Inflammatory bowel diseases, 2017

View PDFchevron_right

Antidepressants and inflammatory bowel disease: a systematic review

Ian Wilson

… in Mental Health, 2006

View PDFchevron_right

Psychotherapy for inflammatory bowel disease: A review and update

Roger Mulder

Journal of Crohn's and Colitis, 2013

View PDFchevron_right